SEPN filings
Corporate insider profile
Daniel D. Long Filing Activity
Latest reported as SVP, Drug Discovery of Septerna, Inc. (SEPN).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$532,581.00
- Latest transaction
- Jun 22, 2026
Affiliated corporations
Reported company relationships
Transaction history
